Computacenter Plc Q1 revenue growth led by North America

Computacenter Plc

Computacenter plc (LON:CCC), a leading independent technology and services provider, has published a trading update, based on unaudited financial information, for the first quarter to 31 March 2025.

Overview

We delivered a good performance for the Group during the first quarter, which was ahead of the prior year and in line with our expectations. Group Technology Sourcing revenue increased strongly against a relatively soft comparison, largely driven by North America. Group Services revenue was also ahead of last year reflecting good growth in Professional Services and a slight decline in Managed Services revenue.

By region, North America continued its momentum and delivered a strong performance reflecting the increased product order backlog position at the end of 2024. The UK achieved good growth in Technology Sourcing and excellent growth in Professional Services. In Germany, given the anticipated temporary reduction in public sector activity following recent elections, the business performed solidly.

Group outlook

At the end of the quarter our committed product order backlog across all regions remained healthy, comfortably exceeding the prior year equivalent position.

With global political and macroeconomic uncertainty increasing in recent weeks the potential impacts on customer demand are difficult to predict. We do not, however, have any direct exposure to tariffs as we meet local demand with local supply within our markets across the Group.

While we are mindful of the more uncertain backdrop, after an encouraging start to the year, we continue to believe we are well positioned to make progress for the year as a whole in constant currency1 and to gain market share.

Our strength in Technology Sourcing, Professional Services and Managed Services, combined with our global reach and our strong balance sheet, mean we remain agile and well placed to help our customers continue to realise the transformative benefits of IT.

Computacenter next scheduled trading update is the announcement of our Half Year Results on 9 September 2025.

1 Foreign exchange rates for 2024 Income Statement: GBP/USD $1.278; GBP/EUR €1.181

Share on:

Latest Company News

Aptamer Group signs first licensing deal with Twist Bioscience

Aptamer Group has entered into its first licensing agreement with Twist Bioscience, granting a non-exclusive licence for the use of an Optimer® binder in hot-start PCR and next-generation sequencing products.

PPHE Hotel Group refinances Park Plaza Victoria London

PPHE Hotel Group has agreed a new £88 million refinancing facility for Park Plaza Victoria London, replacing an existing loan due to mature in early 2026.

Greggs Plc appoints Richard Smothers as Non-Executive Director

Greggs plc has announced the appointment of Richard Smothers as an independent Non-Executive Director, effective from 1 February 2026.

Hollywood Bowl Group reports FY2025 results with revenue growth

Hollywood Bowl Group has published its audited results for the year ended 30 September 2025, reporting revenue growth of 8.8% to £250.7m and a fourth consecutive year of record revenue and adjusted EBITDA.

Centrica Plc agrees sale of Spirit Energy assets to Serica

Centrica has announced the sale of Spirit Energy’s remaining interests in the Cygnus gas field and other producing assets in the Southern North Sea to Serica Energy.

AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer

AstraZeneca and Daiichi Sankyo have received US FDA approval for Enhertu in combination with pertuzumab as a 1st-line treatment for adults with unresectable or metastatic HER2-positive breast cancer.

    Search

    Search